Description
The National Heart, Lung, and Blood Institute (NHLBI); the National Institute of Neurological Disorders and Stroke (NINDS); and National Institute on Aging (NIA) convened a multidisciplinary working group on Future Clinical Trials to Test Promising Approaches for Reducing Vascular Contributions to Cognitive Impairment and Dementia (VCID). The objectives of the working group are to examine lessons learned from recently completed VCID trials and the promise of ongoing trials, and to identify gaps and opportunities for additional trials that may deliver more potent interventions, including both pharmacological and lifestyle interventions that target vascular and other risk factors.